Financial Advisory
We partner with family businesses, founders, corporates, and investors to navigate M&A, licensing, business development, investment, and financing — across Life Sciences and beyond.
Our Services
M&A
Independent advisory on mergers and acquisitions — spanning sell-side, buy-side, and cross-border transactions across sectors and geographies.

Licensing In & Out
End-to-end advisory on licensing in and out — connecting asset owners with the right partners across China, Europe, and North America.
Business Development
Strategic BD advisory to expand commercial footprint internationally — securing partnerships, co-development agreements, and overseas commercial contracts.
Greenfield Investment
Advisory on greenfield investment and market entry — structuring and executing new ventures in international markets from the ground up.

Financing
Discreet and targeted financing advisory — connecting clients with the appropriate capital sources across private and institutional markets.

Life Sciences
M&A, licensing, and BD advisory for biotech, pharma, and CDMO companies across global markets.

Life Sciences
M&A, licensing, and BD advisory for biotech, pharma, and CDMO companies across global markets.
Industrials & Others
Buy-side, sell-side, investment and financing advisory across industrial, energy, and consumer sectors.


Industrials & Others
Buy-side, sell-side, investment and financing advisory across industrial, energy, and consumer sectors.
Independent Counsel Across the Full Transaction Lifecycle
BRP provides end-to-end advisory from initial strategic assessment through execution — with senior involvement at every stage, ensuring consistency of judgement and quality of advice throughout.
Integrated Team Across Disciplines
Our team brings together investment banking, management consulting, and industry expertise. This breadth allows BRP to engage with the commercial, financial, and operational dimensions of each transaction with equal rigour.
Established Access to Chinese Capital and Strategic Partners
BRP maintains substantive relationships across Chinese corporates, pharmaceutical groups, biotech innovators, and industrial enterprises — spanning both inbound and outbound transaction flows. This network affords clients access to counterparties that conventional advisory channels do not reach.
Cross-Border Transaction Expertise
The complexity inherent in cross-border transactions — regulatory, cultural, and commercial — demands advisors with direct experience on both sides. BRP operates across China, Europe, and North America, providing continuity of counsel without loss of strategic clarity.
Commitment to Outcome
BRP measures its performance by the quality of outcomes achieved for clients. Each engagement receives the full attention of the firm's senior advisors, with a standard of execution consistent with that commitment.
Long Term Relationship
Our advisory relationships extend beyond the closing of individual transactions. BRP works alongside clients as their strategic objectives evolve, providing continuity of advice and access to our network over time.
